Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 211

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Macrophage activation-like syndrome: an immunological entity associated with rapid progression to death in sepsis

Open access
on behalf of the Hellenic Sepsis Study Group, Kyriazopoulou, Evdoxia, Leventogiannis, Konstantinos, Norrby-Teglund, Anna, Dimopoulos, Georgios, Pantazi, Aikaterini, Orfanos, Stylianos E., Rovina, Nikoletta, Tsangaris, Iraklis, Gkavogianni, Theologia, Botsa, Elektra, Chassiou, Eleftheria, Kotanidou, Anastasia, Kontouli, Christina, Chaloulis, Panagiotis, Velissaris, Dimitrios, Savva, Athina, Cullberg, Jonas-Sundén, Akinosoglou, Karolina, Gogos, Charalambos, Armaganidis, Apostolos, Giamarellos-Bourboulis, Evangelos J.·2017·BMC Medicine

Abstract

BACKGROUND: A subanalysis of a randomized clinical trial indicated sepsis survival benefit from interleukin (IL)-1 blockade in patients with features of the macrophage activation-like syndrome (MALS). This study aimed to investigate the frequency of MALS and to develop a biomarker of diagnosis and prognosis. METHODS: Patients with infections and systemic inflammatory response syndrome were assigned to one test cohort (n = 3417) and a validation cohort (n = 1704). MALS was diagnosed for patients scoring positive either for the hemophagocytic syndrome score and/or having both hepatobiliary dysfunction and disseminated intravascular coagulation. Logistic regression analysis was used to estimate the predictive value of MALS for 10-day mortality in both cohorts. Ferritin, sCD163, IL-6, IL-10, IL-18, interferon gamma (IFN-γ), and tumor necrosis factor alpha (TNF-α) were measured in the blood the first 24 h; ferritin measurements were repeated in 747 patients on day 3. RESULTS: The frequency of MALS was 3.7% and 4.3% in the test and the validation cohort, respectively. In both cohorts, MALS was an independent risk factor for 10-day mortality. A ferritin level above 4420 ng/ml was accompanied by 66.7% and 66% mortality after 28 days, respectively. Ferritin levels above 4420 ng/ml were associated with an increase of IL-6, IL-18, INF-γ, and sCD163 and a decreased IL-10/TNF-α ratio, indicating predominance of pro-inflammatory phenomena. Any less than 15% decrease of ferritin on day 3 was associated with more than 90% sensitivity for unfavorable outcome after 10 days. This high mortality risk was also validated in an independent Swedish cohort (n = 109). CONCLUSIONS: MALS is an independent life-threatening entity in sepsis. Ferritin measurements can provide early diagnosis of MALS and may allow for specific treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12916-017-0930-5

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 211

Metadata

Authors
on behalf of the Hellenic Sepsis Study Group, Kyriazopoulou, E., Leventogiannis, K., Norrby-Teglund, A., Dimopoulos, G., Pantazi, A., Orfanos, S. E., Rovina, N., Tsangaris, I., Gkavogianni, T., Botsa, E., Chassiou, E., Kotanidou, A., Kontouli, C., Chaloulis, P., Velissaris, D., Savva, A., Cullberg, J.-S., Akinosoglou, K., Gogos, C., Armaganidis, A., & Giamarellos-Bourboulis, E. J.
Venue
BMC Medicine
Published
2017-09-18
Volume
15
Issue
1
Pages
172-172
ISSN
1741-7015 (ISSN-L)
OpenAlex
W2756170974
Cited by
211
References
7
FWCI
12.24
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Macrophage activation-like syndrome: an immunological entity associated with rapid progression to death in sepsis. https://app.cochat.ai/papers/10.1186/s12916-017-0930-5
The paper
on behalf of the Hellenic Sepsis Study Group, Kyriazopoulou, E., Leventogiannis, K., Norrby-Teglund, A., Dimopoulos, G., Pantazi, A., Orfanos, S. E., Rovina, N., Tsangaris, I., Gkavogianni, T., Botsa, E., Chassiou, E., Kotanidou, A., Kontouli, C., Chaloulis, P., Velissaris, D., Savva, A., Cullberg, J.-S., Akinosoglou, K., . . . Giamarellos-Bourboulis, E. J. (2017). Macrophage activation-like syndrome: an immunological entity associated with rapid progression to death in sepsis. BMC Medicine. https://doi.org/10.1186/s12916-017-0930-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.